An interventional study of Data collection and self-administered questionnaire in Surgical Site Infections, Depression and Malnutrition, sponsored by University Hospital, Bordeaux. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-09.
Sponsored by University Hospital, Bordeaux · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Surgical Wound Infection with a site in France — 4 open to participants now, 4 under way, 1 of them phase 3. Surgical Wound Infection · France.
Among the 21 studies in Surgical Wound Infection with a site in France, this one is the 7th largest by planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2025, is one of 6 with no phase, and was the 18th registered.
747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.
Browse Surgical Wound Infection studies →4 of the 21 studies in Surgical Wound Infection with a site in France are open now. Recruiting first, the newest first:
Central Hospital, Nancy, France · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
University Hospital, Clermont-Ferrand · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 200 across 583 interventional studies indexed under Surgical Wound Infection.
Median enrollment 300 across the 13 interventional studies, 134 across the 8 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 21 has an industry lead sponsor. The 10 most frequent:
University Hospital, Bordeaux is the lead sponsor of 807 studies on the registry; 198 are open to participants now.
University Hospital, Bordeaux has 1 study filed under Surgical Wound Infection — fewer than ten, so there is no comparison to draw.
1 of the studies in Surgical Wound Infection with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07558681Central Hospital, Nancy, FrancePerioperative Pharmacokinetic/Pharmacodynamic Target Attainment of Piperacillin During Major Hepatic and Pancreatic Surgery | 2027-01-01 |
Add it to your calendar (.ics) → With an account.
Among the 21 studies in Surgical Wound Infection with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Surgical-site infection (SSI) in orthopedic surgery is a serious and frequent complication with many consequences on the patient's quality of life. This study aims to describe the incidence of depression and its complications like malnutrition in patients followed for surgical site infection to allow their best management and prevention
We will conduct a monocentric (department orthopedic surgery, University Hospital of Bordeaux, France) prospective observational study for 5 years, involving all patients treated for surgical site infection (prosthetic surgery and trauma surgery) The data collected will concern the general condition of the patients, demographic data, information about septic condition, psychiatric disorders, or nutritional conditions, as well as the care provided. A three-year follow-up will be planned
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patient treated in infectiology for surgical site infection after orthopedic surgery of the limbs or spine:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients treated for surgical site infection (prosthetic surgery and trauma surgery)
Other: Data collection and self-administered questionnaire
Exhaustive collection of data in a health data warehouse: collection of clinical, radiological examinations (standard of care), and self-administered questionnaire: a questionnaire concerning the psychological state of the patients (questionnaire according to DSM V) and a questionnaire on nutritional status.
Incidence of Major Depressive Episodes
Incidence of major depressive episodes as defined by the DSM V criteria, screened using the Major Depression Inventory (MDI) score. This will be assessed at baseline (M0) and at subsequent follow-up visits (Weeks 6, Month 3, Month 6 and Month 12).
Time frame: Weeks 6, Month 3, Month 6 and Month 12
Socio-Demographic and Clinical Characteristics
Collection of socio-demographic data including age, sex, employment status, medical and surgical history, and smoking status at baseline and at the end of the study (M12).
Time frame: Baseline (day 0) and 12 months (M12)
Incidence of Malnutrition and Its Risk Factors
\- Malnutrition is defined by weight loss ≥ 5% in 1 month, ≥ 10% in 6 months, or ≥ 10% compared to usual weight before illness (HAS definition); BMI \< 18.5 kg/m².
Time frame: 12 months
Prognostic Significance of Malnutrition and Depression on Infection Treatment Efficacy and Safety
\- Success of infection treatment defined by the cessation of ongoing antibiotic therapy.
Time frame: Baseline (Day 0), Week 6, Month 3, Month 6, and Month 12
Incidence of Malnutrition and Its Risk Factors
Monitoring current nutritional management (oral supplements, nutritional assessments conducted).
Time frame: 12 months
Incidence of Malnutrition and Its Risk Factors
\- Biological criteria for malnutrition: levels of albumin, pre-albumin, folate (B9), and vitamin B12.
Time frame: 12 months
Incidence of Malnutrition and Its Risk Factors
\- Assessment using the Mini Nutritional Assessment (MNA) questionnaire.
Time frame: 12 months
Prognostic Significance of Malnutrition and Depression on Infection Treatment Efficacy and Safety
\- Modifications in infection management due to malnutrition and depression events: treatment discontinuation, therapeutic changes.
Time frame: Baseline ( Day 0), Week 6, Month 3, Month 6, and Month 12
Prognostic Significance of Malnutrition and Depression on Infection Treatment Efficacy and Safety
\- Quality of life scales: SF-36 (SF-36v2® Health Survey ©) and EQ-5D-5L (EuroQol Research Foundation©). These parameters will be assessed at baseline (Day 0) and during follow-up visits (W6, M3, M6, and M12).
Time frame: Baseline (Day0), Week 6, Month 3, Month 6, and Month 12
Started Dec 2025 (actual). Primary completion is estimated for Sep 2026, 9 months after the start.
Of 202 non-industry interventional studies with no phase under Surgical Wound Infection, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's planned 9 months is below that.
Counting every sponsor, half of 209 studies reached it within 24 months; a quarter within 12 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Bordeaux →